Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$101.21 - $166.61 $3,744 - $6,164
-37 Reduced 1.67%
2,175 $258,000
Q1 2024

Apr 23, 2024

SELL
$85.37 - $115.44 $682 - $923
-8 Reduced 0.36%
2,212 $235,000
Q4 2023

Jan 25, 2024

SELL
$69.51 - $104.43 $11,538 - $17,335
-166 Reduced 6.96%
2,220 $220,000
Q3 2023

Oct 18, 2023

BUY
$96.41 - $126.61 $54,182 - $71,154
562 Added 30.81%
2,386 $246,000
Q2 2023

Oct 18, 2023

BUY
$118.5 - $160.53 $216,144 - $292,806
1,824 New
1,824 $221,000
Q4 2022

Jan 26, 2023

BUY
$118.38 - $210.04 $137,675 - $244,276
1,163 New
1,163 $0
Q2 2022

Aug 12, 2022

SELL
$117.13 - $176.59 $139,150 - $209,788
-1,188 Closed
0 $0
Q1 2022

Aug 12, 2022

BUY
$126.46 - $235.05 $150,234 - $279,239
1,188 New
1,188 $205,000
Q3 2021

Nov 12, 2021

SELL
$221.9 - $484.47 $7,100 - $15,503
-32 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$129.91 - $234.98 $4,157 - $7,519
32 New
32 $7,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Strategic Blueprint, LLC Portfolio

Follow Strategic Blueprint, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Blueprint, LLC with notifications on news.